Scales buys Esro stake. Scales Corporation stock falls 1.47 percent

Published on 10/01/2026 at 12:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Scales lifted its outlook to NZD 55.00-60.00 million in fiscal 2026. Scales Corporation stock costs EUR 3.36 on October 1, 2026 versus EUR 3.41.

SCL, NZSCLE0002S8, Illustration mit AI erstellt.

Scales Corporation (ISIN NZSCLE0002S8) was trading at EUR 3.36 at Lang & Schwarz on October 1, 2026 at 12:35 p.m. CEST, down 1.47 percent versus the prior close of EUR 3.41. On September 14, 2026, Scales acquired the remaining 50 percent of Esro Petfood BV for nominal consideration, according to NZX.

Esro becomes fully consolidated

The acquisition gives Scales full ownership of its European pet food ingredient venture and means the company will fully consolidate Esro Petfood results from September 2026. NZX reported that Scales plans to rebrand the business while senior executives work on operating performance and regional stability.

The transaction also carries an operating challenge. News Wire reported on September 14, 2026, that Esro recorded an underlying loss of NZD 5.80 million in the six months ended June 30, 2026, while Scales recorded a NZD 19.70 million impairment provision on its loan to the business.

Revenue more than doubles

Scales entered the transaction from a stronger group position. In the first half of 2026, revenue rose 105.00 percent year over year to NZD 762.10 million, according to FreshPlaza. Underlying EBITDA increased 18.00 percent to NZD 102.20 million, and underlying net profit attributable to shareholders rose 7.00 percent to NZD 52.00 million.

The comparison is important because reported performance and underlying performance diverged. Net profit attributable to equity holders was NZD 30.10 million in the first half of 2026, down from NZD 48.40 million in the first half of 2025, while the underlying measure increased.

Outlook stays at NZD 55 million

Quartr reported that Scales raised fiscal 2026 guidance for underlying net profit attributable to shareholders to NZD 55.00 million to NZD 60.00 million. The same summary gives an underlying EBITDA outlook of NZD 135.00 million to NZD 142.00 million and cites tight supply, geopolitical tensions and final pricing as key operating risks.

Lang & Schwarz quote at EUR 3.36

Scales stock was trading at EUR 3.36 at Lang & Schwarz on October 1, 2026 at 12:35 p.m. CEST, down 1.47 percent versus the Lang & Schwarz prior close of EUR 3.41 on September 30, 2026. The primary NZX quote was NZD 6.73 in the finance snapshot dated October 1, 2026, while the 52-week range was NZD 5.59 to NZD 7.50.